Clinical Trial Update: Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia [Phase 2]

View source ↗

Summary

Phase 2 trial investigating oral low-dose naltrexone for lichen planopilaris and frontal fibrosing alopecia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontal Fibrosing Alopecia
• Lichen Planopilaris

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Lichen Planopilaris, Frontal Fibrosing Alopecia | Phase 2 | Status: COMPLETED | Results posted: 2021-12-30